CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities

Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuron (Cambridge, Mass.) Mass.), 2022-11, Vol.110 (21), p.3549-3565
Hauptverfasser: Franklin, Robin J.M., Simons, Mikael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3565
container_issue 21
container_start_page 3549
container_title Neuron (Cambridge, Mass.)
container_volume 110
creator Franklin, Robin J.M.
Simons, Mikael
description Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals. In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.
doi_str_mv 10.1016/j.neuron.2022.09.023
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2725194263</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0896627322008625</els_id><sourcerecordid>2725194263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</originalsourceid><addsrcrecordid>eNp9kEFP3DAQha0KVJal_6BCOXJJsB3HsTlUqlbdgoTooS1Xy2tPhFexndoOEv--2S7lyGmkmfdm3nwIfSa4IZjw630TYE4xNBRT2mDZYNp-QCuCZV8zIuUJWmEhec1p356h85z3GBPWSfIRnbWcUsFJu0KPm4efVQL_AqMLurgYKh1s5cIwau__NW6qbYq-2unsTOXBPOngss9ViVV5gqQnmMsyidMUU5mDKw7yBTod9Jjh02tdo9_bb782t_X9j-93m6_3tWFYlJozQ5e8PZFaDNgS2VvGOysENktWA5L1jInB7PpBmN1gum7orWgl1pZba1m7RlfHvVOKf2bIRXmXDYyjDhDnrGhPOyIZ5e0iZUepSTHnBIOakvM6vSiC1YGo2qsjUXUgqrBUC9HFdvl6Yd55sG-m_wgXwZejAJY_nx0klY2DYMC6BKYoG937F_4C_02Kig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2725194263</pqid></control><display><type>article</type><title>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Franklin, Robin J.M. ; Simons, Mikael</creator><creatorcontrib>Franklin, Robin J.M. ; Simons, Mikael</creatorcontrib><description>Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals. In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.</description><identifier>ISSN: 0896-6273</identifier><identifier>EISSN: 1097-4199</identifier><identifier>DOI: 10.1016/j.neuron.2022.09.023</identifier><identifier>PMID: 36228613</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Humans ; Inflammation ; Multiple Sclerosis - therapy ; Myelin Sheath - physiology ; Oligodendroglia - physiology ; Remyelination</subject><ispartof>Neuron (Cambridge, Mass.), 2022-11, Vol.110 (21), p.3549-3565</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</citedby><cites>FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</cites><orcidid>0000-0001-6522-2104</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0896627322008625$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36228613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Franklin, Robin J.M.</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><title>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</title><title>Neuron (Cambridge, Mass.)</title><addtitle>Neuron</addtitle><description>Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals. In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.</description><subject>Humans</subject><subject>Inflammation</subject><subject>Multiple Sclerosis - therapy</subject><subject>Myelin Sheath - physiology</subject><subject>Oligodendroglia - physiology</subject><subject>Remyelination</subject><issn>0896-6273</issn><issn>1097-4199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFP3DAQha0KVJal_6BCOXJJsB3HsTlUqlbdgoTooS1Xy2tPhFexndoOEv--2S7lyGmkmfdm3nwIfSa4IZjw630TYE4xNBRT2mDZYNp-QCuCZV8zIuUJWmEhec1p356h85z3GBPWSfIRnbWcUsFJu0KPm4efVQL_AqMLurgYKh1s5cIwau__NW6qbYq-2unsTOXBPOngss9ViVV5gqQnmMsyidMUU5mDKw7yBTod9Jjh02tdo9_bb782t_X9j-93m6_3tWFYlJozQ5e8PZFaDNgS2VvGOysENktWA5L1jInB7PpBmN1gum7orWgl1pZba1m7RlfHvVOKf2bIRXmXDYyjDhDnrGhPOyIZ5e0iZUepSTHnBIOakvM6vSiC1YGo2qsjUXUgqrBUC9HFdvl6Yd55sG-m_wgXwZejAJY_nx0klY2DYMC6BKYoG937F_4C_02Kig</recordid><startdate>20221102</startdate><enddate>20221102</enddate><creator>Franklin, Robin J.M.</creator><creator>Simons, Mikael</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6522-2104</orcidid></search><sort><creationdate>20221102</creationdate><title>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</title><author>Franklin, Robin J.M. ; Simons, Mikael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-64c2097719a8f0d197d465d880c014ce947448fcb7f8cbfc55f7d8390ad6ddd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Humans</topic><topic>Inflammation</topic><topic>Multiple Sclerosis - therapy</topic><topic>Myelin Sheath - physiology</topic><topic>Oligodendroglia - physiology</topic><topic>Remyelination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Franklin, Robin J.M.</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuron (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Franklin, Robin J.M.</au><au>Simons, Mikael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities</atitle><jtitle>Neuron (Cambridge, Mass.)</jtitle><addtitle>Neuron</addtitle><date>2022-11-02</date><risdate>2022</risdate><volume>110</volume><issue>21</issue><spage>3549</spage><epage>3565</epage><pages>3549-3565</pages><issn>0896-6273</issn><eissn>1097-4199</eissn><abstract>Remyelination, the myelin regenerative response that follows demyelination, restores saltatory conduction and function and sustains axon health. Its declining efficiency with disease progression in the chronic autoimmune disease multiple sclerosis (MS) contributes to the currently untreatable progressive phase of the disease. Although some of the bona fide myelin regenerative medicine clinical trials have succeeded in demonstrating proof-of-principle, none of these compounds have yet proceeded toward approval. There therefore remains a need to increase our understanding of the fundamental biology of remyelination so that existing targets can be refined and new ones discovered. Here, we review the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals. In this review, Franklin and Simons discuss the role of inflammation, in particular innate immunity, in remyelination, describing its many and complex facets and discussing how our evolving understanding can be harnessed to translational goals.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36228613</pmid><doi>10.1016/j.neuron.2022.09.023</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0001-6522-2104</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0896-6273
ispartof Neuron (Cambridge, Mass.), 2022-11, Vol.110 (21), p.3549-3565
issn 0896-6273
1097-4199
language eng
recordid cdi_proquest_miscellaneous_2725194263
source MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Humans
Inflammation
Multiple Sclerosis - therapy
Myelin Sheath - physiology
Oligodendroglia - physiology
Remyelination
title CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A06%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CNS%20remyelination%20and%20inflammation:%20From%20basic%20mechanisms%20to%20therapeutic%20opportunities&rft.jtitle=Neuron%20(Cambridge,%20Mass.)&rft.au=Franklin,%20Robin%20J.M.&rft.date=2022-11-02&rft.volume=110&rft.issue=21&rft.spage=3549&rft.epage=3565&rft.pages=3549-3565&rft.issn=0896-6273&rft.eissn=1097-4199&rft_id=info:doi/10.1016/j.neuron.2022.09.023&rft_dat=%3Cproquest_cross%3E2725194263%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2725194263&rft_id=info:pmid/36228613&rft_els_id=S0896627322008625&rfr_iscdi=true